MMS19 and cancer: A connection between CIA-disruption and compromised genomic stability was elegantly shown in a 2018 study by Weon et al. 42, which demonstrated that post-translational regulation of MMS19 via E3 ubiquitin ligase mediated degradation is enhanced in a number of cancers including lung, ovarian, and head and neck cancers.